OUTCOMES OF CHRONICALLY IMMUNOSUPPRESSED PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK.
Christopher M Yao, MD, Samantha Tam, MD, MPH, Mona V Gajera, BS, Neha Desai, MPH, Xiaoning Luo, MD, PhD, Rachel Treistman, BS, Anshu Khanna, MPH, Randal S Weber, MD, Jeffrey N Myers, MD, PhD, Neil D Gross, MD
University of Texas MD Anderson Cancer Center
DEVELOPMENT OF GENE EXPRESSION SIGNATURE FOR RISK ASSESSMENT IN CUTANEOUS SQUAMOUS CELL CARCINOMA WITH A SUBANALYSIS IN THE HEAD AND NECK REGION
Jason G Newman, MD1, Ashley Wysong, MD2, Kyle R Covington, PhD3, Sarah J Kurley, PhD3, Kristen M Plasseraud, PhD3, Robert W Cook, PhD3, Chrysalyne D Schmults, MD, MSCE4, Sarah T Arron, MD, PhD5
1University of Pennsylvania Health System, 2University of Nebraska Medical Center, 3Castle Biosciences, Inc., 4Brigham and Women’s Hospital, 5University of California San Francisco